Literature DB >> 18667633

Circulating 20S proteasome levels in patients with mixed connective tissue disease and systemic lupus erythematosus.

Matthias Majetschak1, Magdalena Perez, Luis T Sorell, Janet Lam, Marcos E Maldonado, Robert W Hoffman.   

Abstract

The associations of circulating 20S proteasomes (c20S) with clinical and serologic disease indices in patients with systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are unknown. We present the initial report that c20S levels are elevated in MCTD and correlate with clinically relevant changes in disease activity in SLE and MCTD.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18667633      PMCID： PMC2546673          DOI： 10.1128/CVI.00187-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  16 in total

Review 1.  The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides.

Authors:  Alfred L Goldberg; Paolo Cascio; Tomo Saric; Kenneth L Rock
Journal:  Mol Immunol       Date:  2002-10       Impact factor: 4.407

2.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

Review 3.  The proteasome: paradigm of a self-compartmentalizing protease.

Authors:  W Baumeister; J Walz; F Zühl; E Seemüller
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

4.  The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B'/B proteins as predominant U1 RNP immunogens.

Authors:  E L Greidinger; R W Hoffman
Journal:  Arthritis Rheum       Date:  2001-02

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.

Authors:  D Alarcón-Segovia; M H Cardiel
Journal:  J Rheumatol       Date:  1989-03       Impact factor: 4.666

7.  Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance.

Authors:  M Wada; M Kosaka; S Saito; T Sano; K Tanaka; A Ichihara
Journal:  J Lab Clin Med       Date:  1993-02

Review 8.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

9.  Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus.

Authors:  J Arribas; M Luz Rodríguez; R Alvarez-Do Forno; J G Castaño
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

10.  Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus.

Authors:  E Feist; T Dörner; U Kuckelkorn; G Schmidtke; B Micheel; F Hiepe; G R Burmester; P M Kloetzel
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307
View more
  15 in total

1.  Immunoproteasome in the blood plasma of children with acute appendicitis, and its correlation with proteasome and UCHL1 measured by SPR imaging biosensors.

Authors:  E Matuszczak; A Sankiewicz; W Debek; E Gorodkiewicz; R Milewski; A Hermanowicz
Journal:  Clin Exp Immunol       Date:  2017-10-16       Impact factor: 4.330

2.  Circulating proteasomes after burn injury.

Authors:  Matthias Majetschak; Siegfried Zedler; Jacqueline Romero; Joslyn M Albright; Robert Kraft; Elizabeth J Kovacs; Eugen Faist; Richard L Gamelli
Journal:  J Burn Care Res       Date:  2010 Mar-Apr       Impact factor: 1.845

3.  Tissue catabolism and donor-specific dexamethasone response in a human osteochondral model of post-traumatic osteoarthritis.

Authors:  Rebecca Mae Black; Lisa L Flaman; Karin Lindblom; Susan Chubinskaya; Alan J Grodzinsky; Patrik Önnerfjord
Journal:  Arthritis Res Ther       Date:  2022-06-10       Impact factor: 5.606

4.  Proteasomes in human bronchoalveolar lavage fluid after burn and inhalation injury.

Authors:  Joslyn M Albright; Jacqueline Romero; Vikas Saini; Stephan U Sixt; Melanie D Bird; Elizabeth J Kovacs; Richard L Gamelli; Jürgen Peters; Matthias Majetschak
Journal:  J Burn Care Res       Date:  2009 Nov-Dec       Impact factor: 1.845

5.  Concentration of Proteasome in the Blood Plasma of Children with Acute Appendicitis, Before and After Surgery, and Its Correlation with CRP.

Authors:  Ewa Matuszczak; Marzena Tylicka; Wojciech Dębek; Anna Sankiewicz; Ewa Gorodkiewicz; Adam Hermanowicz
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

6.  The value of correlation of serum 20S proteasome concentration and percentage of lymphocytic apoptosis in critically ill patients: a prospective observational study.

Authors:  Ayman A Yousef; Ghada A Suliman; Maaly M Mabrouk
Journal:  Crit Care       Date:  2010-11-25       Impact factor: 9.097

Review 7.  Regulating the 20S proteasome ubiquitin-independent degradation pathway.

Authors:  Gili Ben-Nissan; Michal Sharon
Journal:  Biomolecules       Date:  2014-09-23

8.  Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes.

Authors:  Z Zhang; L Song; K Maurer; M A Petri; K E Sullivan
Journal:  Genes Immun       Date:  2009-08-27       Impact factor: 2.676

9.  T lymphocytes export proteasomes by way of microparticles: a possible mechanism for generation of extracellular proteasomes.

Authors:  Isabel Bochmann; Frédéric Ebstein; Andrea Lehmann; Jeremias Wohlschlaeger; Stephan Urs Sixt; Peter-Michael Kloetzel; Burkhardt Dahlmann
Journal:  J Cell Mol Med       Date:  2013-10-31       Impact factor: 5.310

10.  Circulating proteasome activity following mild head injury in children.

Authors:  Marzena Tylicka; Ewa Matuszczak; Wojciech Dębek; Adam Hermanowicz; Halina Ostrowska
Journal:  Childs Nerv Syst       Date:  2014-04-04       Impact factor: 1.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.